← All organizations

Kantar Health

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 27, 2014

Acquired by Cerner on Dec 17, 2020

Timeline

2000s

Jun 1, 2009
Kantar Health— Founded

2020s

Dec 17, 2020
Cerner— Acquired By

Drugs by trial phase (3 distinct, 1 trials)

Phase 3 (3 own, 0 via acquisition)

Indications

Studied for

Neuroendocrine Tumors

Recent trials (1)

NCT02246127CollaboratorPhase 3Oct 27, 2014

Details

Founded: New York, NY, US Jun 1, 2009
Last known activity: Oct 27, 2014